Table 1.
Heterogeneity of skin ILC2.
Cell identity | |||
---|---|---|---|
Cell types | Detection | Characteristics | References |
Mouse | |||
ILC2 | Flow cytometry | Detected by expression of ST2 and CD25 Detected by expression of IL-7R, ICOS and c-Kit |
(5, 46) (7) |
IL-13 producing ILC2 | Flow cytometry in IL-13 reporter mice | (6) | |
IL-5 producing ILC2 | Single cell and bulk RNAseq in IL-5 reporter mice | High expression of Gata3, Il7r, Crlf2, Icos, Ccr6, Itgae, Il18r1, low expression of Il1rl1 | (8) |
IL-13 producing ILC2 | Flow cytometry in IL-13 reporter mice | High expression of ICOS, low expression of ST2 | (10) |
Epidermal ILC Dermal ILC |
Single cell and bulk RNAseq and flow cytometry | High expression of CCR6, CD103, Rorc, Lta, Il13 (ILC3-like) High expression of ICOS, Gata3 |
(9) |
ST2+ ILC2 in subcutis | High expression of ST2, CD25, Sca-1, KLRG1, Gata3, Il5 | ||
Inflammatory ILC2 | Single cell RNAseq and flow cytometry | Expression of GATA3, RORγt, CCR6, production of IL-5, IL-13 and IL-17A | (40) |
Human | |||
ILC2 | Flow cytometry | Detected by expression of ST2 and CD25 Detected by expression of IL-7Ra and CRTH2 |
(5, 22) (7) |
ILC2 | Immunohistochemistry | Expression of GATA3, IL-7Ra and CRTH2 | (21) |
ILC2 | Single cell RNAseq | Expression of GATA3 and RORA | (23) |
Mixed ILC2 and ILC3 | Coexpression of GATA3, RORC, AHR, IL5, IL13, IL22, IL26 (increase in atopic skin) | ||
Cytokine response | |||
Activating cytokines | Mice | Models | References |
TSLP | Tslp−/− (C57BL/6) | MC903 atopic-like dermatitis | (5) |
IL-33 |
Il1rl1−/− (BALB/c) Il1rl1−/− hK14mIL33tg (C57BL/6) |
MC903 atopic-like dermatitis Wound healing IL-33 overexpression in keratinocytes |
(7) (46) (26) |
IL-25 | Il17rb−/− (BALB/c) | MC903 atopic-like dermatitis | (7) |
K14-Cre Il25flox/flox (C57BL/6) Rora-Cre Il17rbflox/flox (BALB/c) |
OVA allergic skin inflammation | (27) | |
IL-18 |
Il18−/− (C57BL/6) KIL-18Tg (C57BL/6) |
MC903 atopic-like dermatitis IL-18 overexpression in keratinocytes |
(8) (28) |